Table 2 |
||
|
Proportion of Case Reports Reporting Critical Information |
||
|
Critical Element |
Percent Reporting |
95% Confidence Interval |
|
|
||
|
Description of Patient and Disease |
||
|
|
||
|
Age and gender |
99 |
95 – 100 |
|
|
||
|
Definition, severity and stage of disease |
88.1 |
79 – 93 |
|
|
||
|
Co-Morbid conditions |
45.2 |
35 – 56 |
|
|
||
|
Patient medications |
29.7 |
21 – 40 |
|
|
||
|
Description of Interventions |
||
|
|
||
|
Route or dose of medications or details of procedure described |
79.7 |
70 – 87 |
|
|
||
|
Co-interventions |
57.1 |
46 – 67 |
|
|
||
|
Description of Outcomes |
||
|
|
||
|
Clinically relevant outcomes defined |
90.4 |
82 – 95 |
|
|
||
|
Side effects reported |
33.3 |
24 – 44 |
|
|
||
|
Threats to Generalizability anad Validity |
||
|
|
||
|
Generalizability |
28.6 |
20 – 39 |
|
|
||
|
Alternative explanations |
27.4 |
19 – 38 |
|
|
||
|
Information about denominator |
2.3 |
1 – 8 |
|
|
||
|
Richason et al. BMC Emergency Medicine 2009 9:10 doi:10.1186/1471-227X-9-10 |
||